News - Vaccinogen http://vaccinogeninc.investorroom.com/ Vaccinogen Announces Filing of Oncavert® Patent Application http://vaccinogeninc.investorroom.com/2016-06-16-Vaccinogen-Announces-Filing-of-Oncavert-Patent-Application Establishing a Concept and Pathway to the Development of an Adenocarcinoma Prevention Vaccine Thu, 16 Jun 2016 11:32:00 -0400 http://vaccinogeninc.investorroom.com/2016-06-16-Vaccinogen-Announces-Filing-of-Oncavert-Patent-Application Vaccinogen Believes That Its "Whole-Tumor Methodology" and Focus on "Cancer Heterogeneity" is Supported by Research Published in The Proceedings of the National Academy of Sciences (PNAS) http://vaccinogeninc.investorroom.com/2015-12-02-Vaccinogen-Believes-That-Its-Whole-Tumor-Methodology-and-Focus-on-Cancer-Heterogeneity-is-Supported-by-Research-Published-in-The-Proceedings-of-the-National-Academy-of-Sciences-PNAS Peer-Reviewed Article Concludes That Extreme Intratumor Diversity, Even in Small Tumors, Suggests a Need to Reevaluate Treatment Strategies Wed, 02 Dec 2015 10:32:00 -0500 http://vaccinogeninc.investorroom.com/2015-12-02-Vaccinogen-Believes-That-Its-Whole-Tumor-Methodology-and-Focus-on-Cancer-Heterogeneity-is-Supported-by-Research-Published-in-The-Proceedings-of-the-National-Academy-of-Sciences-PNAS Vaccinogen Promotes Peter Morsing, Ph.D. to Chief Operating Officer http://vaccinogeninc.investorroom.com/2015-11-04-Vaccinogen-Promotes-Peter-Morsing-Ph-D-to-Chief-Operating-Officer Dr. Morsing to Lead Vaccinogen's Clinical, Logistical, Manufacturing and Business Development Activities Wed, 04 Nov 2015 07:33:00 -0500 http://vaccinogeninc.investorroom.com/2015-11-04-Vaccinogen-Promotes-Peter-Morsing-Ph-D-to-Chief-Operating-Officer Vaccinogen Engages D. Barry Boyd, M.D., M.S., as Senior Oncology Advisor http://vaccinogeninc.investorroom.com/2015-10-28-Vaccinogen-Engages-D-Barry-Boyd-M-D-M-S-as-Senior-Oncology-Advisor Veteran Medical Oncologist Joins Vaccinogen's Medical Advisory Board to Advance its Promising Immunotherapies Wed, 28 Oct 2015 07:33:00 -0400 http://vaccinogeninc.investorroom.com/2015-10-28-Vaccinogen-Engages-D-Barry-Boyd-M-D-M-S-as-Senior-Oncology-Advisor Vaccinogen Appoints Michael G. Hagerman to its Board of Directors http://vaccinogeninc.investorroom.com/2015-10-06-Vaccinogen-Appoints-Michael-G-Hagerman-to-its-Board-of-Directors Tue, 06 Oct 2015 07:33:00 -0400 http://vaccinogeninc.investorroom.com/2015-10-06-Vaccinogen-Appoints-Michael-G-Hagerman-to-its-Board-of-Directors Vaccinogen Enhances Patient-Derived Antibody Program with Revolutionary High-Throughput Single Cell Screening and Analysis System http://vaccinogeninc.investorroom.com/news?item=40 Secures Option Agreement with Dublin City University to Acquire DiCAST Platform Wed, 09 Sep 2015 07:30:00 -0400 http://vaccinogeninc.investorroom.com/news?item=40 Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board http://vaccinogeninc.investorroom.com/2015-05-05-Vaccinogen-Names-Co-Founder-and-CEO-Andrew-L-Tussing-as-Chairman-of-the-Board Benjamin S. Carson, Sr., MD Steps Down from Board of Directors, Chairman Role and Medical Advisory Board to Focus on His Candidacy for the Republican Presidential Nomination Tue, 05 May 2015 07:00:00 -0400 http://vaccinogeninc.investorroom.com/2015-05-05-Vaccinogen-Names-Co-Founder-and-CEO-Andrew-L-Tussing-as-Chairman-of-the-Board Vaccinogen Relocates Corporate Headquarters to Baltimore http://vaccinogeninc.investorroom.com/2015-02-24-Vaccinogen-Relocates-Corporate-Headquarters-to-Baltimore Move puts company in ideal position to attract top scientific and medical talent to advance OncoVAX® clinical trial Tue, 24 Feb 2015 07:00:00 -0500 http://vaccinogeninc.investorroom.com/2015-02-24-Vaccinogen-Relocates-Corporate-Headquarters-to-Baltimore Vaccinogen Elects Ronald Kaiser to Board of Directors http://vaccinogeninc.investorroom.com/2015-02-17-Vaccinogen-Elects-Ronald-Kaiser-to-Board-of-Directors Entrepreneur and executive leader brings more than 35 years of financial and accounting expertise to company Tue, 17 Feb 2015 07:00:00 -0500 http://vaccinogeninc.investorroom.com/2015-02-17-Vaccinogen-Elects-Ronald-Kaiser-to-Board-of-Directors Vaccinogen Elects Håkan Edström to Board of Directors http://vaccinogeninc.investorroom.com/2015-02-10-Vaccinogen-Elects-Hakan-Edstrom-to-Board-of-Directors Established business leader brings more than 40 years of pharmaceutical operations and commercialization expertise to the company Tue, 10 Feb 2015 07:00:00 -0500 http://vaccinogeninc.investorroom.com/2015-02-10-Vaccinogen-Elects-Hakan-Edstrom-to-Board-of-Directors